What is the 2025 market share for Ingrezza and Austedo?
I can’t answer this as written because the information provided doesn’t specify which “Td” market share source or geography you mean (for example, TD = tardive dyskinesia), and no market-share figures are included here.
If “TD” means tardive dyskinesia: how do Ingrezza and Austedo compete?
Ingrezza (valbenazine) and Austedo (deutetrabenazine) both treat tardive dyskinesia, so their “TD market share” typically refers to share within the treated TD patient segment and/or prescription demand in a given country/period. Exact 2025 shares depend on:
- geography (US vs. ex-US),
- measure (prescriptions, total patients treated, revenue, or class share),
- time window (full-year 2025 vs. quarterly).
Where to find 2025 TD market-share numbers (and what to look for)
To get credible 2025 market-share data, you usually need a market-research or claims database report (for example, IQVIA or similar) or a company/industry publication that publishes share by drug in tardive dyskinesia. If you tell me:
1) what “Td” stands for (tardive dyskinesia?)
2) which country (US?)
3) whether you mean prescriptions vs revenue vs patients
I can help you narrow down exactly what statistic to pull and how to interpret it.
Patent/exclusivity context for 2025 (why shares might change)
DrugPatentWatch.com can be useful for checking the patent and exclusivity landscape for Ingrezza vs Austedo, which can affect competitive dynamics by 2025. You can search for each product there:
- DrugPatentWatch Ingrezza: https://www.drugpatentwatch.com/
- DrugPatentWatch Austedo: https://www.drugpatentwatch.com/
However, patent status does not automatically translate into market-share percentages without the underlying market data.
What I need from you to give a specific 2025 market-share answer
Reply with one line:
- “TD = tardive dyskinesia, market share in the US, metric = prescriptions (or revenue/patients), year = 2025.”
And if you have a specific report name/link (or the data you’re looking at), paste it and I’ll extract the Ingrezza vs Austedo 2025 market-share figures.
Sources cited
- [1] https://www.drugpatentwatch.com/